BRAVO esophageal pH monitoring measures acid exposure in the esophagus over several days using a small capsule placed during a sedated endoscopy. The capsule transmits data to a wearable recorder while you go about normal activities. The results help your provider understand reflux patterns and guide treatment decisions.
Let your doctor know if you have an implanted electronic device such as a pacemaker or implantable cardiac defibrillator (ICD), a history of bleeding problems, dilated blood vessels, a nickel allergy, or any other previously known problems with your esophagus.
If you have diabetes or are taking medications for weight loss, use the following instructions:
Preparation involves medication planning and fasting before capsule placement, followed by several days of monitoring. You’ll wear the recorder, track symptoms in a diary, and return the equipment after the study is complete. Detailed instructions and exact timing are provided below.
If you take GLP-1 medications (Ozempic (Semaglutide), Mounjaro (Trizepatide) or ANY GLP-1) - DO NOT TAKE 7-DAYS PRIOR TO YOUR PROCEDURE
If you take SGLT2 medications (Jardiance, Farxiga, Invokana, Steglatro, Brenzavvy, Glyxambi, Synjardy, Xigduo, Qtern) - DO NOT TAKE 3 DAYS PRIOR TO YOUR PROCEDURE. If you are taking any of these medications, use the following instructions.
THE DAY BEFORE YOUR PROCEDURE
THE DAY OF YOUR PROCEDURE
THE DAY OF YOUR PROCEDURE
If your insurance requires a referral or prior authorization, our billing office will make every effort to obtain it before services are rendered. If you choose to proceed without required authorization, insurance may deny coverage. If you are a Medicare patient, you may be asked to sign an Advanced Beneficiary Notice (ABN) acknowledging financial responsibility if insurance does not pay. If you are enrolled in a commercial insurance plan you will be asked to sign a non-covered services form.